New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
PHASE3
The purpose of this study is to compare the efficacy and safety of the fixe...
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
PHASE3
The purpose of this study is to compare the efficacy and safety of the fixe...
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiFormā¢) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
PHASE3
The medications being used in this study are individually approved by the F...